Stocktoria

MYRIAD GENETICS INC MYGN

Nasdaq · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1995-10-06 · LEI

MYRIAD GENETICS INC statistics & valuation

Market cap$555.4M
P / S0.7×
P / B1.5×
Net margin-44.4%
Return on equity-99.4%
Net cash$29.7M
Enterprise value USD$525.7M
Earnings yield EBIT/EV-73.7%
Return on capital-67.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
2.30% 17.90% 0.50% -31.20% -40.10% -3.90% -16.50% -35.00% -15.20% -44.40% 2017201820192020202020212022202320242025
Gross margin (%)
70.20% 68.60% 69.90% 69.90% 2017201820192020202020212022202320242025
Operating margin (%)
5.70% 16.40% 0.90% -36.30% -52.00% -27.60% -20.70% -34.20% -14.70% -47.00% 2017201820192020202020212022202320242025
Return on equity (%)
2.30% 13.80% 0.40% -21.70% -25.40% -2.80% -12.60% -33.60% -18.20% -99.40% 2017201820192020202020212022202320242025
Shares outstanding
68.8M 72.0M 76.0M 74.7M 75.4M 80.0M 81.2M 89.9M 91.3M 93.5M 2017201820192020202020212022202320242025
Net debt ($)
-$3.3M -$101.6M $140.3M $60.7M $107.8M -$257.4M -$56.9M -$93.6M -$62.8M -$29.7M 2017201820192020202020212022202320242025
Share buybacks ($)
2017201820192020202020212022202320242025
Return on assets (%)
1.40% 11.30% 0.30% -14.20% -15.80% -2.10% -9.30% -23.00% -12.40% -51.80% 2017201820192020202020212022202320242025
Free cash flow margin (%)
2017201820192020202020212022202320242025
Debt / equity (×)
0.13× 0.01× 0.21× 0.24× 0.26× 0.00× 0.00× 0.05× 0.06× 0.33× 2017201820192020202020212022202320242025
EPS ($)
$0.25 $1.85 $0.06 -$2.69 -$2.99 -$0.35 -$1.39 -$3.18 -$1.41 -$3.95 2017201820192020202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

MYRIAD GENETICS INC trades at about 53.8× earnings — above its 10-year norm (10-year range 16×–485.7×, median 23.6×).

16× 485.7×

Shaded band = 10-year range (16×–485.7×); dot = today's 53.8×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2020FY2019FY2018FY2017
Gross margin69.9%69.9%68.6%70.2%——————
Operating margin-47.0%-14.7%-34.2%-20.7%-27.6%-52.0%-36.3%0.9%16.4%5.7%
Net margin-44.4%-15.2%-35.0%-16.5%-3.9%-40.1%-31.2%0.5%17.9%2.3%
Return on assets-51.8%-12.4%-23.0%-9.3%-2.1%-15.8%-14.2%0.3%11.3%1.4%
Return on equity-99.4%-18.2%-33.6%-12.6%-2.8%-25.4%-21.7%0.4%13.8%2.3%
Debt / equity0.33×0.06×0.05×0.00×0.00×0.26×0.24×0.21×0.01×0.13×
Current ratio2.491.822.012.002.372.672.262.963.211.39

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.